• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心绞痛且冠状动脉无阻塞患者的心理负担:被低估、未充分探究、治疗不足。

Psychological burden in patients with angina and unobstructed coronary arteries-underestimated, underexplored, undertreated.

机构信息

Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Auerbachstr. 110, 70376, Stuttgart, Germany.

Department of Psychosomatic Medicine, Robert-Bosch-Krankenhaus, Stuttgart, Germany.

出版信息

Herz. 2024 Aug;49(4):277-281. doi: 10.1007/s00059-024-05253-2. Epub 2024 Jun 19.

DOI:10.1007/s00059-024-05253-2
PMID:38896153
Abstract

Patients with angina and unobstructed coronary arteries (ANOCA) are frequently encountered in clinical practice. These cases represent a diagnostic and therapeutic challenge and are often characterized by a long patient journey until a diagnosis of coronary vasomotor disorders is established. Moreover, the unsatisfactory management of such patients leads to insecurity, ongoing symptoms, and psychological sequelae such as anxiety or depression. Currently, the psychological burden in patients with ANOCA is underestimated, underexplored, and undertreated. This review gives a new perspective on the pathophysiology of coronary vasomotor disorders including psychological risk factors and calls for comprehensive care by interdisciplinary ANOCA clinics.

摘要

临床上经常会遇到心绞痛且冠状动脉无阻塞(ANOCA)的患者。这些病例构成了诊断和治疗方面的挑战,通常表现为患者需要经历漫长的就诊过程,直到确定为冠状动脉血管舒缩功能障碍的诊断。此外,此类患者的治疗效果不理想会导致其产生不安全感,持续出现症状,并产生焦虑或抑郁等心理后遗症。目前,ANOCA 患者的心理负担被低估、研究不足且治疗不足。本综述从包括心理危险因素在内的冠状动脉血管舒缩功能障碍的病理生理学方面提供了新的视角,并呼吁通过ANOCA 多学科临床团队提供全面的护理。

相似文献

1
Psychological burden in patients with angina and unobstructed coronary arteries-underestimated, underexplored, undertreated.心绞痛且冠状动脉无阻塞患者的心理负担:被低估、未充分探究、治疗不足。
Herz. 2024 Aug;49(4):277-281. doi: 10.1007/s00059-024-05253-2. Epub 2024 Jun 19.
2
Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.血管舒缩功能障碍在心绞痛和非阻塞性冠状动脉疾病患者中主要表现为血管痉挛。
Int J Cardiol. 2021 Jun 15;333:14-20. doi: 10.1016/j.ijcard.2021.02.079. Epub 2021 Mar 10.
3
Prevalence of Coronary Vasomotor Disorders in Patients With Angina and Nonobstructive Coronary Arteries: A Sydney Experience.心绞痛伴非阻塞性冠状动脉疾病患者的冠状动脉舒缩功能障碍患病率:悉尼经验。
Heart Lung Circ. 2024 Sep;33(9):1297-1306. doi: 10.1016/j.hlc.2024.02.020. Epub 2024 Jun 25.
4
Objective Ischemia, Subjective Angina, and Psychological Distress in Angina With No Obstructive Coronary Disease.无阻塞性冠状动脉疾病的心绞痛中的客观缺血、主观心绞痛和心理困扰。
J Am Heart Assoc. 2024 Aug 6;13(15):e034644. doi: 10.1161/JAHA.124.034644. Epub 2024 Jul 31.
5
Multivessel Coronary Function Testing Increases Diagnostic Yield in Patients With Angina and Nonobstructive Coronary Arteries.多血管冠状动脉功能检测可提高心绞痛伴非阻塞性冠状动脉疾病患者的诊断效果。
JACC Cardiovasc Interv. 2024 May 13;17(9):1091-1102. doi: 10.1016/j.jcin.2024.03.007.
6
High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries).在稳定型心绞痛且冠状动脉无阻塞的患者中,乙酰胆碱检测存在病理性反应的高发率。ACOVA 研究(稳定型心绞痛和冠状动脉无阻塞患者的异常冠状动脉血管舒缩功能)。
J Am Coll Cardiol. 2012 Feb 14;59(7):655-62. doi: 10.1016/j.jacc.2011.11.015.
7
Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein.在冠状动脉无阻塞的患者中,乙酰胆碱诱导的冠状动脉痉挛与可溶性CD40配体浓度升高及高敏C反应蛋白有关。
Coron Artery Dis. 2015 Mar;26(2):126-32. doi: 10.1097/MCA.0000000000000181.
8
The role of myocardial blood volume in the pathophysiology of angina with non-obstructed coronary arteries: The MICORDIS study.心肌血容量在非阻塞性冠状动脉心绞痛病理生理学中的作用:MICORDIS 研究。
Int J Cardiol. 2024 Nov 15;415:132479. doi: 10.1016/j.ijcard.2024.132479. Epub 2024 Aug 22.
9
Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries.血管舒缩功能在伴有心绞痛和无阻塞性冠状动脉疾病患者中的性别差异。
J Am Coll Cardiol. 2017 Nov 7;70(19):2349-2358. doi: 10.1016/j.jacc.2017.09.016.
10
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.地尔硫䓬改善非冠状动脉粥样硬化性急性冠状动脉综合征患者冠状动脉血管运动功能障碍的疗效:EDIT-CMD 随机临床试验。
JACC Cardiovasc Imaging. 2022 Aug;15(8):1473-1484. doi: 10.1016/j.jcmg.2022.03.012. Epub 2022 Apr 2.

本文引用的文献

1
Genetic associations of cardiovascular risk genes in European patients with coronary artery spasm.冠状动脉痉挛欧洲患者心血管风险基因的遗传相关性。
Clin Res Cardiol. 2024 Dec;113(12):1733-1744. doi: 10.1007/s00392-024-02446-x. Epub 2024 Apr 18.
2
Usefulness of wearable electrocardiography devices in patients experiencing paroxysmal cardiac-related symptoms: A case series of the "CardioSecur" system.可穿戴式心电图设备在阵发性心脏相关症状患者中的应用:“CardioSecur”系统的病例系列
Am Heart J Plus. 2023 Mar 31;29:100295. doi: 10.1016/j.ahjo.2023.100295. eCollection 2023 May.
3
Increased Angio-Derived Index of Microcirculatory Resistance Within a Timeframe of 30-60 days After COVID-19 Infection.
在感染 COVID-19 后 30-60 天的时间内,微血管阻力的血管源性指数增加。
Microcirculation. 2024 Apr;31(3):e12851. doi: 10.1111/micc.12851. Epub 2024 Mar 18.
4
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.活动性长新冠伴有血栓炎症迹象的持续补体失调。
Science. 2024 Jan 19;383(6680):eadg7942. doi: 10.1126/science.adg7942.
5
Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function.重新思考通过评估冠状动脉微血管功能来纠正运动心电图压力测试中的假阳性结果。
J Am Coll Cardiol. 2024 Jan 16;83(2):291-299. doi: 10.1016/j.jacc.2023.10.034.
6
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.稳定型缺血性心脏病患者管理模式的演变:JACC 本周综述主题。
J Am Coll Cardiol. 2023 Feb 7;81(5):505-514. doi: 10.1016/j.jacc.2022.08.814.
7
Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international.无阻塞性冠状动脉疾病的心肌缺血(INOCA):来自INOCA国际组织的患者生活质量自我报告调查
Int J Cardiol. 2023 Jan 15;371:28-39. doi: 10.1016/j.ijcard.2022.09.047. Epub 2022 Sep 23.
8
Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial.无阻塞性冠状动脉疾病的缺血:来自 ISCHEMIA 试验的见解。
JACC Cardiovasc Imaging. 2023 Jan;16(1):63-74. doi: 10.1016/j.jcmg.2022.06.015. Epub 2022 Sep 14.
9
Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases.长新冠与心血管系统:阐明病因和细胞机制,以制定靶向诊断和治疗策略:ESC 心肌和心包疾病工作组与心脏细胞生物学工作组的联合科学声明。
Cardiovasc Res. 2023 Mar 31;119(2):336-356. doi: 10.1093/cvr/cvac115.
10
Vasospastic Angina: A Cause of Post-acute COVID-19 Syndrome.血管痉挛性心绞痛:急性 COVID-19 综合征后的一个病因
Intern Med. 2022 Sep 1;61(17):2693-2695. doi: 10.2169/internalmedicine.0137-22. Epub 2022 Jun 28.